Global Transdermal Skin Patches Market: Industry Analysis and Forecast 2020-2026, By Type, Application and Region

Global Transdermal Skin Patches Market is expected to reach US$ 10.5 Bn. at a CAGR of 2.7 during the forecast period 2026.

Global Transdermal Skin Patches Market Definition

A transdermal patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. The transdermal drug delivery system (TDDS) is a painless, non-invasive method of drug delivery and takes precedence over other conventional delivery routes.

Global Transdermal Skin Patches Market Dynamics

Transdermal therapeutic delivery in gastric irritation, pH balance, and Diabetes mellitus show the systemic delivery of drug and reduce the risk of systemic side effects. Sustained release of drug at the site of application and rapid termination of therapy by removal of formulation make the treatment applicable mostly for chronic disorders. There are also combination patches for contraception, as well as hormone replacement. Oestradiol patches have the highest production by key players and are used by more than a million patients annually and, in contrast to oral formulations, do not cause liver damage. Now a day, transdermal patches are widely used as cosmetic, topical and transdermal delivery systems. Clinical observations and evidence-based studies in skin cancer, technology and expertise developed skin patch products represent a key outcome in the global transdermal skin patched market. Innovation, technology, strong R & D and promising solutions for better health are the driving factors for the global market. The successful merger and acquisition activities among key players and leading suppliers of life-saving drugs to various organizations in the Asia Pacific and the world over is commended the rapid growth rate of the global market in the forecast period.

Global Transdermal Skin Patches Market Segment Analysis

Global Transdermal Skin Patches Market To know about the Research Methodology :- Request Free Sample Report

Single-Layer Drug-in Adhesive have the highest demand by Cosmetologists for skincare treatment.

Single-layer Drug-in Adhesive is, by and large, inexpensive and convenient treatment for patients who want to get rid of remembering to take tablets/pills, and is a relief for their caregivers. The technique works as a self-administered, non-invasive, painless tool and typically allows less frequent or one-time dosing application in comparison to oral and other routes of administration. Development of drug-in-adhesive transdermal patches and in vivo pharmacokinetics & efficacy evaluation is projected largest share of XX% in the global market.

Transdermal Skin Patches have their large contribution to relieving pain during all treatment procedures.

Adoption of the commercial transdermal device and non-inflammatory products on the market for local pain relief is expected to anticipate the global market in the forecast period. The transdermal skin patches are largely utilized for arthritis and chronic back pain especially to reduce back pain. The prevalence of pain in cancer patients is between 30–50% with pain becoming much more common as the cancer advances. Transdermal opioids are safe, effective, and produce significantly fewer side effects than oral morphine when used for moderate to severe cancer pain.

Global Transdermal Skin Patches Market Regional Analysis

North America commanded the largest share of XX% in the global transdermal skin patches market and it is expected to maintain its dominance in the forecast period. Early use of topical therapy and the development of topical products in the 20th century are driving the global market from North America. Adoptions of adhesive transdermal delivery devices in the treatment and procedures increase the demand for transdermal patches in this region. The presence of major manufacturing companies includes Teva Pharmaceutical Industries, Mylan Pharmaceuticals Inc, 3M Company are fuel the global transdermal skin patches market. The recently developed/ to-be-launched Transdermal Skin Patch Products in the forecast period 2020-2026. Global Transdermal Skin Patches Market 2 The objective of the report is to present a comprehensive analysis of the global transdermal skin patches market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding the global transdermal skin patches market dynamics, structure by analyzing the market segments and project the global transdermal skin patches market clear representation of competitive analysis of key players by price, financial position, by detection and equipment portfolio, growth strategies, and regional presence in the global transdermal skin patches market make the report investor’s guide.

Scope of the Global Transdermal Skin Patches Market Report: Inquire before buying

Global Transdermal Skin Patches Market 3

Global Transdermal Skin Patches Market, by Region

• North America • Europe • Asia Pacific • Middle East and Africa • South America

Global Transdermal Skin Patches Market Key Players

• Teva Pharmaceutical Industries Ltd. • Mylan Pharmaceuticals Inc • 3M Company • Accrux Ltd. • Access Pharmaceuticals Inc. • Novartis AG • Teikoku Pharma USA Inc • Hisamitsu Pharmaceutical • UCB • GlaxoSmithKline • Boehringer Ingelheim • Johnson & Johnson • Endo International • Purdue Pharma • Chrono Therapeutics • CeQur • Agile Therapeutics • Allergan • ANI Pharmaceuticals • Antares Pharma • Bayer HealthCare Pharmaceuticals • Chase Pharmaceuticals
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Transdermal Skin Patches Market Size, by Market Value (US$ Bn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2019 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Transdermal Skin Patches Market 3.4. Geographical Snapshot of the Transdermal Skin Patches Market, By Manufacturer share 4. Global Transdermal Skin Patches Market Overview, 2019-2026 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Products 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Transdermal Skin Patches Market 5. Supply Side and Demand Side Indicators 6. Global Transdermal Skin Patches Market Analysis and Forecast, 2019-2026 6.1. Global Transdermal Skin Patches Market Size & Y-o-Y Growth Analysis. 7. Global Transdermal Skin Patches Market Analysis and Forecasts, 2019-2026 7.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 7.1.1. Single-layer Drug-in-Adhesive 7.1.2. Multiple-layer Drug-in-Adhesive 7.1.3. Matrix 7.1.4. Others 7.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 7.2.1. Pain Relief 7.2.2. Smoking Reduction and Cessation Aid 7.2.3. Overactive Bladder 7.2.4. Hormonal Therapy 7.2.5. Other Applications 8. Global Transdermal Skin Patches Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2019-2026 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Transdermal Skin Patches Market Analysis and Forecasts, 2019-2026 9.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 9.1.1. Single-layer Drug-in-Adhesive 9.1.2. Multiple-layer Drug-in-Adhesive 9.1.3. Matrix 9.1.4. Others 9.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 9.2.1. Pain Relief 9.2.2. Smoking Reduction and Cessation Aid 9.2.3. Overactive Bladder 9.2.4. Hormonal Therapy 9.2.5. Other Applications 10. North America Transdermal Skin Patches Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Transdermal Skin Patches Market Analysis and Forecasts, 2019-2026 11.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 11.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 12. Canada Transdermal Skin Patches Market Analysis and Forecasts, 2019-2026 12.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 12.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 13. Mexico Transdermal Skin Patches Market Analysis and Forecasts, 2019-2026 13.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 13.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 14. Europe Transdermal Skin Patches Market Analysis and Forecasts, 2019-2026 14.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 14.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 15. Europe Transdermal Skin Patches Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. Transdermal Skin Patches Market Analysis and Forecasts, 2019-2026 16.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 16.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 17. France Transdermal Skin Patches Market Analysis and Forecasts, 2019-2026 17.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 17.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 18. Germany Transdermal Skin Patches Market Analysis and Forecasts, 2019-2026 18.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 18.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 19. Italy Transdermal Skin Patches Market Analysis and Forecasts, 2019-2026 19.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 19.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 20. Spain Transdermal Skin Patches Market Analysis and Forecasts, 2019-2026 20.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 20.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 21. Sweden Transdermal Skin Patches Market Analysis and Forecasts, 2019-2026 21.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 21.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 22. CIS Countries Transdermal Skin Patches Market Analysis and Forecasts, 2019-2026 22.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 22.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 23. Rest of Europe Transdermal Skin Patches Market Analysis and Forecasts, 2019-2026 23.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 23.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 24. Asia Pacific Transdermal Skin Patches Market Analysis and Forecasts, 2019-2026 24.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 24.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 25. Asia Pacific Transdermal Skin Patches Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Transdermal Skin Patches Market Analysis and Forecasts, 2019-2026 26.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 26.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 27. India Transdermal Skin Patches Market Analysis and Forecasts, 2019-2026 27.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 27.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 28. Japan Transdermal Skin Patches Market Analysis and Forecasts, 2019-2026 28.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 28.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 29. South Korea Transdermal Skin Patches Market Analysis and Forecasts, 2019-2026 29.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 29.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 30. Australia Transdermal Skin Patches Market Analysis and Forecasts, 2019-2026 30.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 30.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 31. ASEAN Transdermal Skin Patches Market Analysis and Forecasts, 2019-2026 31.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 31.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 32. Rest of Asia Pacific Transdermal Skin Patches Market Analysis and Forecasts, 2019-2026 32.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 32.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 33. Middle East Africa Transdermal Skin Patches Market Analysis and Forecasts, 2019-2026 33.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 33.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 34. Middle East Africa Transdermal Skin Patches Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2019-2026 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Transdermal Skin Patches Market Analysis and Forecasts, 2019-2026 35.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 35.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 36. GCC Countries Transdermal Skin Patches Market Analysis and Forecasts, 2019-2026 36.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 36.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 37. Egypt Transdermal Skin Patches Market Analysis and Forecasts, 2019-2026 37.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 37.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 38. Nigeria Transdermal Skin Patches Market Analysis and Forecasts, 2019-2026 38.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 38.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 39. Rest of ME&A Transdermal Skin Patches Market Analysis and Forecasts, 2019-2026 39.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 39.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 40. South America Transdermal Skin Patches Market Analysis and Forecasts, 2019-2026 40.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 40.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 41. South America Transdermal Skin Patches Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2019-2026 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Transdermal Skin Patches Market Analysis and Forecasts, 2019-2026 42.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 42.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 43. Argentina Transdermal Skin Patches Market Analysis and Forecasts, 2019-2026 43.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 43.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 44. Rest of South America Transdermal Skin Patches Market Analysis and Forecasts, 2019-2026 44.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 44.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Transdermal Skin Patches Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Applications and R&D Investment 45.2.2. New Product Launches and Product Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile : Key Players 45.3.1 Teva Pharmaceutical Industries LTD 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Product Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. Mylan Pharmaceuticals Inc 45.3.3. 3M Company 45.3.4. Accrux Ltd. 45.3.5. Access Pharmaceuticals Inc. 45.3.6. Novartis AG 45.3.7. Teikoku Pharma USA Inc 45.3.8. Hisamitsu Pharmaceutical 45.3.9. UCB 45.3.10. GlaxoSmithKline 45.3.11. Boehringer Ingelheim 45.3.12. Johnson & Johnson 45.3.13. Endo International 45.3.14. Purdue Pharma 45.3.15. Chrono Therapeutics 45.3.16. CeQur 45.3.17. Agile Therapeutics 45.3.18. Allergan 45.3.19. ANI Pharmaceuticals 45.3.20. Antares Pharma 45.3.21. Bayer HealthCare Pharmaceuticals 45.3.22. Chase Pharmaceuticals 46. Primary Key Insights

About This Report

Report ID 36276
Category Healthcare
Published Date Nov 2019
Updated Date Nov 2021
Contact Us